Simplifying HIV cohort monitoring- Pharmacy stock records minimize resources necessary to determine retention in care

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 3, 2013, Pages

  Orrell, Catherine ^a   Dipenaar, Riana ^a   Killa, Nicola ^a   Tassie, Jean Michel ^b   Harries, Anthony D ^c,d   Wood, Robin ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MONITORING; PHARMACY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

EID: 85027956723     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827e6080     Document Type: Letter

References (10)

1. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access. 2011 Progress Report. 2011. Available at: http://www.afro.who.int/en/clusters-a-programmes/dpc/acquiredimmune-deficiency- syndrome/features/3439-global-hivaids-response-progress-report-2011.html Accessed January 5, 2012.
2. Douglas GP, Gadabu OJ, Joukes S, et al. Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLOS Med 2010; 7:e1000319.
3. Harries AD, Schouten EJ, Makombe SD, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ. 2007; 85:152-155.
4. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-Infected South African adults. J Acquir Immune Defic Syndr. 2006; 43:78-84.
5. Wood R, Kaplan R, Bekker LG, et al. The utility of pharmacy dispensing data for ART programme evaluation and early identification of patients lost to follow-up. South Afr J HIV Med 2008;9:44-48.
6. Johnson LF, Middelkoop K, Kranzer K, et al. A model of the impact of HIV/AIDS and antiretroviral therapy in the Masiphumelele Community. 2011. Available at: http://www.cider.uct.ac.za/publications/publications-rep.php. Accessed December 19, 2012.
7. South African National Antiretroviral Treatment Guidelines, National Department of Health, South Africa. 1st ed. National Department of Health, South Africa; 2004. Available at: http://www.hst.org.za/uploads/files/sa-ART- Guidelines1.pdf Accessed June 12, 2012.
8. National Department of Health SA. Clinical Guidelines for the Management of HIV & AIDS in Adults and Adolescents. National Department of Health SA; 2010. Available at: http://www.fidssa.co.za/Guidelines/2010-Adult-ART- Guidelines.pdf Accessed April 25, 2012.
9. Kranzer K, Lewis JJ, Ford N, et al. Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J. Acquir Immune Defic Syndr. 2010;55:e17-e23.
10. Sanne I, Orrell C, Fox MP, et al; for the CIPRA-SA Study Team. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. 2010;376: 33-40.